Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Total assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Total Assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Award Timing Predetermined Award Timing Predetermined [Flag] Indefinite-Lived Intangible Assets [Axis] Indefinite-Lived Intangible Assets [Axis] Entity File Number Entity File Number Additional Paid-In Capital Additional Paid-in Capital [Member] Tabular List, Table Tabular List [Table Text Block] Recently Adopted Accounting Pronouncements and Recent Accounting Pronouncements Not Adopted New Accounting Pronouncements, Policy [Policy Text Block] Purchases of available-for-sale investments Payments to Acquire Short-Term Investments SOFR Secured Overnight Financing Rate (SOFR) [Member] Indemnification holdback Business Combination, Consideration Transferred, Liabilities Incurred Measurement Basis [Axis] Measurement Basis [Axis] Adjustment to Compensation: Adjustment to Compensation [Axis] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] REVENUE Revenue from Contract with Customer [Text Block] Common stock issued under employee stock purchase plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Vested restricted stock units (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Number of embedded leases Number Of Leases Number Of Leases In-process research and development (IPR&D) Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, In Process Research And Development Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, In Process Research And Development Jonathan Slonin [Member] Jonathan Slonin Adjustment to Compensation, Amount Adjustment to Compensation Amount Percentage of revenue from customers to total revenue Concentration risk Concentration Risk, Percentage Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Stock options Weighted average number of stock options Share-Based Payment Arrangement, Option [Member] Schedule of Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Amortization expense, seventh period Finite-Lived Intangible Asset, Expected Amortization, Year Seven Finite-Lived Intangible Asset, Expected Amortization, Year Seven Antidilutive Securities [Axis] Antidilutive Securities [Axis] Impairments Asset Impairment Charges Total stockholders’ equity Balance at beginning of period Balance at ending of period Equity, Attributable to Parent Insider Trading Policies and Procedures [Line Items] Schedule of Fixed Assets Summarized by Major Category Property, Plant and Equipment [Table Text Block] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Weighted average interest rate Line of Credit Facility, Interest Rate at Period End LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Cover page. Cover [Abstract] Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Foreign Currency Adjustments Indefinite-Lived Intangible Assets (Excluding Goodwill), Accumulated Foreign Currency Translation Adjustments Indefinite-Lived Intangible Assets (Excluding Goodwill), Accumulated Foreign Currency Translation Adjustments Maximum Maximum Maximum [Member] Bridge Loan Bridge Loan [Member] Number of shares reserved for issuance (in shares) Share Repurchase Program, Remaining Authorized, Number of Shares Intangible Assets, Net Finite-Lived Intangible Assets, Net Discount rate Debt Instrument, Discount Rate Debt Instrument, Discount Rate Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Debt Instrument [Line Items] Debt Instrument [Line Items] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Contingent Consideration Contingent Consideration [Member] Contingent Consideration [Member] Carrying value of impairment of intangible assets Impairment of Intangible Assets, Carrying Value Impairment of Intangible Assets, Carrying Value Deferred tax liability Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liability Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liability Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Purchase of capped calls Adjustments To Additional Paid In Capital, Purchase Of Capped Calls, Before Tax Adjustments To Additional Paid In Capital, Purchase Of Capped Calls, Before Tax Broker fees Share Repurchase Program, Broker Fees Share Repurchase Program, Broker Fees Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Term three Debt Conversion Terms Three [Member] Debt Conversion Terms Three Income (loss) before income taxes Income (loss) before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Entity Shell Company Entity Shell Company Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Key employee holdback recognition year three Business Combination, Liabilities Arising from Contingencies, Percent, Year Three Business Combination, Liabilities Arising from Contingencies, Percent, Year Three Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Beginning balance Ending balance Restructuring Reserve Letter of Credit Letter of Credit [Member] Domestic Income (Loss) from Continuing Operations before Income Taxes, Domestic Schedule of Recognized Stock-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Lease liabilities Operating Lease, Liability, Current Terms one Debt Conversion Terms One [Member] Debt Conversion Terms One Wells Fargo Bank Wells Fargo Bank, National Association, Credit Agreement [Member] Wells Fargo Bank, National Association, Credit Agreement Document Fiscal Period Focus Document Fiscal Period Focus Award Timing Method Award Timing Method [Text Block] Litigation Case [Domain] Litigation Case [Domain] ESPP purchasing period Share-Based Compensation Arrangement By Share-based Payment Award, Purchase Period Share-Based Compensation Arrangement By Share-based Payment Award, Purchase Period Office furniture and equipment Furniture and Fixtures [Member] Right-of-use assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Right Of Use Assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Right Of Use Assets Award Type [Axis] Award Type [Axis] Unrealized Foreign Currency Translation Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Trading Symbol Trading Symbol 2029 Lessee, Operating Lease, Liability, to be Paid, Year Four Percentage of last reported sale price of common stock Debt Instrument, Convertible, Threshold Percentage Of Stock Trading Price Debt Instrument, Convertible, Threshold Percentage Of Stock Trading Price Proceeds from shares issued under employee stock purchase plan Proceeds From Shares Issued Under Employee Stock Purchase Plans The cash inflow from shares issued under Employee Stock Purchase Plans. Entity Address, City or Town Entity Address, City or Town Total identifiable net assets acquired Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Identifiable Net Assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Identifiable Net Assets Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Restricted stock units Weighted average number of RSUs Restricted Stock Units (RSUs) [Member] Income Statement Location [Domain] Statement of Income Location, Balance [Domain] Pre-tax employee termination benefit charges Severance Costs Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Purchase price consideration of 81% of GQ Bio Business Combination, Consideration Transferred Schedule of Intangible Assets Business Combination, Intangible Asset, Acquired, Finite-Lived [Table Text Block] Required principal repayment on conversion Debt Instrument, Repurchased In Conversion Face Amount Debt Instrument, Repurchased In Conversion Face Amount Investment impairment Equity Method Investment, Other-than-Temporary Impairment Entity Emerging Growth Company Entity Emerging Growth Company Outstanding beginning of period (in shares) Outstanding end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Repayment of Revolving Credit Facility Repayments of Lines of Credit Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Deferred financing costs Debt Issuance Costs, Net Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Gross Carrying Value Intangible Assets, Net Indefinite-Lived Intangible Assets (Excluding Goodwill) Common stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Number of offering periods for ESPP Share-Based Compensation Arrangement By Share-based Payment Award, Number Of Purchase Periods Share-Based Compensation Arrangement By Share-based Payment Award, Number Of Purchase Periods Schedule of Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Indemnification repayment period Business Acquisition, Indemnification Duration Business Acquisition, Indemnification Duration Accrued income taxes Accrued Income Taxes, Current Exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Long-term Growth Long-term Growth [Member] Long-term Growth Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Number of Restricted Stock Units Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Restatement Determination Date Restatement Determination Date Income tax expense Income tax expense Income tax expense Income Tax Expense (Benefit) Net leverage ratio Debt Instrument, Basis Spread on Variable Rate Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value Inducement Plan 2014 Inducement Plan 2014 [Member] Inducement Plan 2014 Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Amortization expense, eighth period Finite-Lived Intangible Asset, Expected Amortization, Year Eight Finite-Lived Intangible Asset, Expected Amortization, Year Eight Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Total Property, Plant and Equipment, Gross Kristen Williams [Member] Kristen Williams Purchases of debt investments Payments to Acquire Long-Term Investments Payment term Contingent Consideration, Payment Term Contingent Consideration, Payment Term Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Goodwill arising from the GQ Bio Acquisition Goodwill, Acquired During Period Proceeds from exercises of stock options Proceeds from Stock Options Exercised Acquisition of GQ Bio Therapeutics GmbH (net of cash acquired) Payments to Acquire Businesses, Net of Cash Acquired All Trading Arrangements All Trading Arrangements [Member] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Repurchase price percent Debt Instrument, Redemption Price, Percentage Accrued expenses Accrued Liabilities, Current Unvested at beginning of period (in shares) Unvested at end of period in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Legal judgment Payment received Legal judgment Litigation Settlement, Gain Net cash provided by operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Subsequent Event Subsequent Event [Member] Schedule of Valuation Assumptions Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Sales of available-for-sale investments Proceeds from Sale of Short-Term Investments PEO Total Compensation Amount PEO Total Compensation Amount Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Depreciation expense Depreciation Concentration of products (in products) Concentration Risk, Number Of Products Concentration Risk, Number Of Products Amortization expense, remainder of fiscal year Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year ASSETS ACQUIRED Business Combination, Recognized Asset Acquired, Asset [Abstract] Equity Components [Axis] Equity Components [Axis] FIXED ASSETS Property, Plant and Equipment [Line Items] Convertible Debt Convertible Debt [Member] Sublease income Sublease Income Acquisition agreement Business Combination, Consideration Transferred Gross Business Combination, Consideration Transferred Gross Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Net product sales Total net product sales Product [Member] Number of reportable segments Number of Reportable Segments Key assumptions Business Combination, Contingent Consideration, Liability, Measurement Input Expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Entity Address, State or Province Entity Address, State or Province Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] EBITDA (in percent) Debt Instrument, Covenant, Incremental Debt, Maximum Percent Debt Instrument, Covenant, Incremental Debt, Maximum Percent Total current liabilities Liabilities, Current Total workforce (in percent) Restructuring and Related Cost, Number of Positions Eliminated, Period Percent Individual: Individual [Axis] Research and development Research and Development Expense [Member] Fixed assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Disposals Property, Plant and Equipment, Disposals Entity Interactive Data Current Entity Interactive Data Current Adjusted selling and marketing Selling And Marketing, Adjusted Selling And Marketing, Adjusted Periodic payment, principal Debt Instrument, Periodic Payment, Principal Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Ownership [Domain] Ownership [Domain] Name of Major Customer [Domain] Customer [Domain] Entity Central Index Key Entity Central Index Key PEO Name PEO Name Financial Assets: Receivables, Fair Value Disclosure [Abstract] Initial conversion price of notes into common stock (in dollars per share) Debt Instrument, Convertible, Conversion Price Asset retirement obligation Asset Retirement Obligation Cash and cash equivalents Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash And Cash Equivalents Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash And Cash Equivalents Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Fair Value Measurements Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value FINANCIAL INSTRUMENTS Financial Instruments Disclosure [Text Block] Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Work-in-process Inventory, Work in Process, Net of Reserves Exercise Price Award Exercise Price Entity Filer Category Entity Filer Category Subsequent Event Type [Axis] Subsequent Event Type [Axis] Long-term debt, net Long-Term Debt, Excluding Current Maturities Nonrelated Party Nonrelated Party [Member] Amortization expense, third period Finite-Lived Intangible Asset, Expected Amortization, Year Three Volumes distributed in US market in duration period Litigation Settlement, Volume-Limited, Increase Period Litigation Settlement, Volume-Limited, Increase Period Gross Carrying Value Finite-Lived Intangible Assets, Gross Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Entity Address, Address Line One Entity Address, Address Line One Research and development Research and Development Expense Accumulated Other Comprehensive Income AOCI Attributable to Parent [Member] Amount of allowance for doubtful accounts Accounts Receivable, Allowance for Credit Loss, Current Capped Call Capped Call [Member] Capped Call Common stock withheld for employee withholding tax liabilities on vested restricted stock units (in shares) Withheld shares in common stock (in shares) Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Settlement of previous amount Business Combination, Preacquisition Receivable, Settlement, Amount Business Combination, Preacquisition Receivable, Settlement, Amount Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract] Ownership [Axis] Ownership [Axis] Fair Value as of Grant Date Award Grant Date Fair Value Income tax payable Accrued Income Taxes Schedule of Long-Term Debt Instruments Schedule of Long-Term Debt Instruments [Table Text Block] Dilutive effect of share based compensation arrangements (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Total operating expenses Costs and Expenses Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Acquired identifiable IPR&D assets discount Acquired Identifiable In Process Research and Development, Measurement Input Acquired Identifiable In Process Research and Development, Measurement Input Document Quarterly Report Document Quarterly Report Schedule of Key Assumptions used in the Valuation of Contingent Consideration Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Counterparty Name [Domain] Counterparty Name [Domain] 2027 Lessee, Operating Lease, Liability, to be Paid, Year Two Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Accrued expenses Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Expenses Non-cancelable contractual commitment remaining three months of 2025 Contractual Obligation, to be Paid, Remainder of Fiscal Year Title Trading Arrangement, Individual Title Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Cash consideration paid at closing Payments to Acquire Businesses, Gross Non-PEO NEO Non-PEO NEO [Member] Common stock issued under employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Cash payment of GQ Bio Acquisition transaction expenses Business Combination, Consideration Transferred, Tangible and Intangible Assets, Excluding Cash Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Upfront payments Advance Milestone Payments Advance Milestone Payments Adjusted general and administrative Selling, General And Administrative Adjusted Selling, General And Administrative Adjusted Term Loan A Facility Term Loan A Facility [Member] Term Loan A Facility Gross Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Equity Award [Domain] Award Type [Domain] 2026 Lessee, Operating Lease, Liability, to be Paid, Year One Equity Awards Adjustments Equity Awards Adjustments [Member] Leasehold improvements Leasehold Improvements [Member] MyoScience Milestone Litigation MyoScience Milestone Litigation [Member] MyoScience Milestone Litigation Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Lease liabilities Business Combination, Recognized Liability Assumed, Lease Obligation Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Compensation Amount Outstanding Recovery Compensation Amount Schedule of Acquisition-Related Charges (Gain), Restructuring Charges and Other COMMERCIAL PARTNERS AND OTHER AGREEMENTS [Table Text Block] COMMERCIAL PARTNERS AND OTHER AGREEMENTS [Table Text Block] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Fair Value Measurements Using Estimate of Fair Value Measurement [Member] Amortization expense, sixth period Finite-Lived Intangible Asset, Expected Amortization, Year Six Finite-Lived Intangible Asset, Expected Amortization, Year Six MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Debt Instrument, Convertible Terms Of Conversion [Domain] Debt Instrument, Convertible Terms Of Conversion [Domain] Debt Instrument, Convertible Terms Of Conversion [Domain] Changes in contingent consideration Contingent consideration charges (gains) Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) Weighted average ESPP share options Employee stock purchase plan share options Employee Stock [Member] Revenues: Revenues [Abstract] Accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss), Net of Tax Johnson & Johnson MedTech Johnson & Johnson MedTech [Member] Johnson & Johnson MedTech Financial Instruments [Domain] Financial Instruments [Domain] Purchases Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Royalty revenue Royalty [Member] Inventories, net Total Inventory, Net Developed technologies Developed Technology Rights [Member] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Minimum Minimum [Member] Investments and other assets Equity Method Investments and Other Assets Equity Method Investments and Other Assets 3.375% Convertible senior notes due May 2024 Convertible Senior Notes Due 2024 [Member] Convertible Senior Notes Due 2024 Goodwill Goodwill, Measurement Period Adjustment Company Selected Measure Name Company Selected Measure Name Fair Value Measurement [Domain] Fair Value Measurement [Domain] Schedule of Available-for-sale Securities [Table] Schedule of Short-Term and Noncurrent Available-For-Sale Investments [Table] Schedule of Short-Term and Noncurrent Available-For-Sale Investments DEBT Debt Disclosure [Text Block] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Accounts payable Accounts Payable, Current Cash paid for operating lease liabilities, net of lease incentives Operating Lease, Payments Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Other liabilities Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Liabilities Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Liabilities Impairment of acquired IPR&D Impairment of Intangible Assets (Excluding Goodwill) Stockholders' Equity Note [Abstract] Stockholders' Equity Note [Abstract] Adjusted cost of goods sold Cost Of Goods Sold, Adjusted Cost Of Goods Sold, Adjusted Restructuring Plan [Domain] Restructuring Plan [Domain] Goodwill [Roll Forward] Goodwill [Roll Forward] COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Diluted (in shares) Weighted average number of shares outstanding - diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Reconciliation of Assets from Segment to Consolidated [Table] Reconciliation of Assets from Segment to Consolidated [Table] Entity Small Business Entity Small Business Percentage of voting interests acquired Business Combination, Voting Equity Interest Acquired, Percentage Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Measurement Period Adjustments Business Combination, Provisional Information [Abstract] Document Transition Report Document Transition Report Other noncurrent assets Business Combination, Recognized Asset Acquired, Other Asset, Noncurrent Schedule of Percentage of Revenue Comprised of the Three Largest Customers Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Underlying Securities Award Underlying Securities Amount Equity Component [Domain] Equity Component [Domain] Document Period End Date Document Period End Date INCOME TAXES Income Tax Disclosure [Text Block] Third largest wholesaler Third Largest Customer [Member] Represents the third largest customer of the entity. Proceeds from Revolving Credit Facility Proceeds from Lines of Credit Key employee holdback recognition year two Business Combination, Liabilities Arising from Contingencies, Percent, Year Two Business Combination, Liabilities Arising from Contingencies, Percent, Year Two Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Amortization of debt discount Amortization of Debt Discount (Premium) Document Type Document Type Level 3 Fair Value, Inputs, Level 3 [Member] NET INCOME (LOSS) PER COMMON SHARE Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Loss Contingencies [Table] Loss Contingencies [Table] Additional paid-in capital Additional Paid in Capital Product and Service [Axis] Product and Service [Axis] Legal settlement Litigation Settlement, Loss Variable lease costs Variable Lease, Cost Total revenues Total net product sales Revenue from Contract with Customer, Excluding Assessed Tax Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Convertible note receivable Payments to Acquire Notes Receivable Additional interest payment Litigation Settlement Interest Aggregate purchase Share Repurchase Program, Authorized, Amount Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Payment of employee withholding taxes on restricted stock unit vests Payment, Tax Withholding, Share-Based Payment Arrangement Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Total other comprehensive income Other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Current liabilities: Liabilities, Current [Abstract] Gross deferred tax assets Deferred Tax Assets, Tax Credit Carryforwards, Research Ownership Business Combination, Achieved in Stages, Preacquisition Equity Interest in Acquiree, Percentage Agreement period of volumes distributed in market Litigation Settlement, Volume-Limited, Maximum Percentage, Period Litigation Settlement, Volume-Limited, Maximum Percentage, Period Level 1 Fair Value, Inputs, Level 1 [Member] Outstanding Long-Term Line of Credit Increasing modestly period Litigation Settlement, Volume-Limited, Number Of Moderate Increase Periods Litigation Settlement, Volume-Limited, Number Of Moderate Increase Periods Stock-based compensation from: Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Accounts payable Business Combination, Recognized Liability Assumed, Accounts Payable, Current Accrued expenses and income taxes payable Increase (Decrease) in Accrued Liabilities Diluted net income (loss) per common share (in dollars per share) Earnings Per Share, Diluted Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Accelerated depreciation expense Restructuring and Related Cost, Accelerated Depreciation AOCI Attributable to Parent, Net of Tax [Roll Forward] AOCI Attributable to Parent, Net of Tax [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Excise tax on share repurchases included in accrued liabilities Share Repurchase Program, Excise Tax, Payable Treasury stock (in shares) Treasury Shares, Beginning balance (in shares) Treasury Shares, Ending balance (in shares) Treasury Stock, Common, Shares ZILRETTA ZILRETTA [Member] ZILRETTA Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Net cash paid for income taxes Income Taxes Paid, Net Corporate bonds Corporate Bond Securities [Member] Amortization expense, second period Finite-Lived Intangible Asset, Expected Amortization, Year Two Long-term debt Long-Term Debt, Gross Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Market price of principal amount of notes Debt Instrument, Market Price Debt market price, per $1,000 principal amount. FIXED ASSETS Property, Plant and Equipment Disclosure [Text Block] Total future lease payments Lessee, Operating Lease, Liability, to be Paid Net unrealized gain (loss) on investments, net of tax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Expiration Date Trading Arrangement Expiration Date Settlement period - convertible debt conversion request Settlement Period - Convertible Debt Conversion Request The number of trading days in a settlement period for convertible debt conversion requests. Other liabilities Increase (Decrease) in Other Operating Liabilities Amortization expense, fifth period Finite-Lived Intangible Asset, Expected Amortization, Year Five Fixed assets, net Fixed assets, net Property, Plant and Equipment, Net Restructuring charges Charges incurred Restructuring Charges Accounts payable Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable, Current Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable, Current Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Accounts receivable, net Increase (Decrease) in Accounts Receivable Schedule of Restructuring and Related Costs [Table] Restructuring Cost [Table] Scheduled trading day Debt Instrument, Convertible, Redemption, Trading Days From Maturity Debt Instrument, Convertible, Redemption, Trading Days From Maturity Entity Current Reporting Status Entity Current Reporting Status Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Proceeds from 2029 convertible senior notes Proceeds from Convertible Debt Financial Instrument [Axis] Financial Instrument [Axis] Purchase of capped calls, tax Adjustments To Additional Paid In Capital, Purchase Of Capped Calls, Tax Adjustments To Additional Paid In Capital, Purchase Of Capped Calls, Tax Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Executive Category: Executive Category [Axis] Repayments of debt Repayments of Debt STOCK PLANS Compensation and Employee Benefit Plans, Other than Share-Based Compensation [Text Block] Reserve of raw materials Inventory Valuation Reserves Current Fiscal Year End Date Current Fiscal Year End Date Expected term of options Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Other Other Cost of Operating Revenue Other liabilities Business Combination, Recognized Liability Assumed, Other Liability, Current Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Weighted Average Grant Date Fair Value (Per Share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Number of shares remain available for issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Number of employees Restructuring and Related Cost, Number of Positions Eliminated Weighted average fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Total identifiable net assets acquired Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) Antidilutive effects of including these potential shares (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Weighted average common shares outstanding: Denominator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] LEASES Lessee, Operating Leases [Text Block] Net cash (used in) provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Measure: Measure [Axis] Financial Liabilities: Financial Liabilities Fair Value Disclosure [Abstract] Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Vested restricted stock units Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Remaining available for future purchases Share Repurchase Program, Remaining Authorized, Amount Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Amortization of debt issuance costs Amortization of debt issuance costs Amortization of Debt Issuance Costs Entity Tax Identification Number Entity Tax Identification Number Number of customers Concentration Risk, Number of Customers Concentration Risk, Number of Customers Outstanding beginning of period (in dollars per share) Outstanding at end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Common stock, shares issued (in shares) Common Stock, Shares, Issued Weighted average remaining lease term (in years) Operating Lease, Weighted Average Remaining Lease Term GOODWILL AND INTANGIBLE ASSETS Goodwill and Intangible Assets Disclosure [Text Block] Payment received Proceeds from Legal Settlements Schedule of Goodwill Schedule of Goodwill [Table Text Block] Interest expense Interest Expense, Nonoperating Trading Arrangement: Trading Arrangement [Axis] Total Shareholder Return Amount Total Shareholder Return Amount Fair value of impairment of intangible assets Impairment Of Intangible Assets, Fair Value Impairment Of Intangible Assets, Fair Value Loss Contingencies [Line Items] Loss Contingencies [Line Items] Foreign currency adjustments Fair value adjustments and accretion Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Security Exchange Name Security Exchange Name Major Customer One Major Customer One [Member] Represents the major customer of the entity. Fixed assets included in accounts payable and accrued liabilities Capital Expenditures Incurred but Not yet Paid Commitment amount Line of Credit Facility, Maximum Borrowing Capacity Indefinite-Lived Intangible Assets, Major Class Name [Domain] Indefinite-Lived Intangible Assets, Major Class Name [Domain] Operating expenses: Operating Expenses [Abstract] Flexion Flexion Therapeutics, Inc. [Member] Flexion Therapeutics, Inc. Realized gain of prior investments Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings Prior 19% equity investment ownership of GQ Bio realized upon business combination Business Combination, Achieved in Stages, Preacquisition Equity Interest in Acquiree, Fair Value Statement [Line Items] Statement [Line Items] Statement [Line Items] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Computer equipment and software Computer Equipment and Software [Member] Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems. Cash and cash equivalents Cash and Cash Equivalent Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Subsequent Event [Line Items] Subsequent Event [Line Items] Additional shares (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Common Shares Common Stock [Member] Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Net (decrease) increase in cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] Statistical Measurement [Domain] Statistical Measurement [Domain] Fixed assets Business Combination, Recognized Asset Acquired, Property, Plant, and Equipment Yankee bond Yankee Bond [Member] Yankee Bond Major Customer Two Major Customer Two [Member] Represents the major customer of the entity. 2025 (remaining three months) Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Gross Carrying Value Intangible Assets, Gross (Excluding Goodwill) Leases [Abstract] Leases [Abstract] Intangible Asset, Acquired, Finite-Lived [Line Items] Intangible Asset, Acquired, Finite-Lived [Line Items] Accounts payable Increase (Decrease) in Accounts Payable Type of Restructuring [Domain] Type of Restructuring [Domain] Common stock withheld for employee withholding tax liabilities on vested restricted stock units Common stock withheld for employee tax Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Gross Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Employee termination benefits Employee Benefit and Share-Based Payment Arrangement, Noncash Probability of payment for remaining regulatory milestone Measurement Input, Expected Milestone Payment [Member] Measurement Input, Expected Milestone Payment [Member] Basic net income (loss) per common share (in dollars per share) Earnings Per Share, Basic Commercial paper Commercial Paper [Member] CONTINGENT CONSIDERATION CHARGES (GAINS), ACQUISITION-RELATED EXPENSES, RESTRUCTURING AND OTHER Business Combination, Integration, Restructuring, and Other Related Costs [Text Block] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Right-of-use assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Right-of-Use Assets Discount rates Measurement Input, Discount Rate [Member] Schedule of Reconciliation of Significant Expense Categories Schedule of Segment Reporting Information, by Segment [Table Text Block] Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Threshold percentage stock price trigger Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger Measurement Input Type [Domain] Measurement Input Type [Domain] Schedule of Short-Term and Noncurrent Available-for-Sale Investments Schedule of Available-for-Sale Securities Reconciliation [Table Text Block] Key employee holdback expenses Business Combination, Accrued Key Employee Holdback Business Combination, Accrued Key Employee Holdback Probability of successful development and commercialization Measurement Input, Discount for Lack of Marketability [Member] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Accrued excise tax Share Repurchase Program, Excise Tax Repayments for royalties Repayments for royalties Litigation Settlement, Amount Awarded from Other Party Balloon payment to be paid Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid Total Share-Based Payment Arrangement, Expense Segment Reporting, Asset Reconciling Item [Line Items] Segment Reporting, Asset Reconciling Item [Line Items] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Current assets: Assets, Current [Abstract] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Total liabilities and stockholders’ equity Liabilities and Equity EARNINGS PER SHARE Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Number of Stock Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Threshold consecutive trading days Debt Instrument, Convertible, Threshold Consecutive Trading Days Accounting Policies [Abstract] Accounting Policies [Abstract] Schedule of Maturities of Operating Lease Liabilities Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Repayment of Term loan A facility Repayments of Secured Debt Treasury Shares Treasury Stock, Common [Member] Pay vs Performance Disclosure [Line Items] U.S. federal agency bonds US Government Agencies Debt Securities [Member] Total operating lease liabilities Operating Lease, Liability Other noncurrent assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent GQ BIO THERAPEUTICS ACQUISITION Business Combination [Text Block] Other liabilities Other Liabilities, Noncurrent Investments Without Readily Determinable Fair Value Roll Forward [Abstract] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Goodwill impairment Goodwill impairment Goodwill, Impairment Loss Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Company Selected Measure Amount Company Selected Measure Amount 2028 Lessee, Operating Lease, Liability, to be Paid, Year Three Comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Expired (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Measurement Input Type [Axis] Measurement Input Type [Axis] Name Measure Name Schedule of (Loss) Income Before Income Taxes and Income Tax Expense Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Term Loan Secured Debt [Member] Schedule of Change in Contingent Consideration Recorded at Fair Value using Level 3 Measurements Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Deferred tax liabilities Deferred Income Tax Liabilities, Net Unsecured Debt Unsecured Debt [Member] Total Total debt, net of deferred financing costs Long-Term Debt Legal Entity [Axis] Legal Entity [Axis] Total assets Assets Investing activities: Cash Provided by (Used in) Investing Activity, Continuing Operation [Abstract] Amortization expense, first period Finite-Lived Intangible Asset, Expected Amortization, Year One Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Number of major customers Number of Major Customers Represents the number of major customers of the reporting entity. Geographical [Domain] Geographical [Domain] Receivable Type [Axis] Receivable Type [Axis] Aggregate principal amount Debt Instrument, Covenant, Incremental Debt, Maximum Debt Instrument, Covenant, Incremental Debt, Maximum Weighted-Average Useful Lives Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life Concentration Risk Type [Axis] Concentration Risk Type [Axis] INVENTORIES Inventory Disclosure [Text Block] Amortization expense, fourth period Finite-Lived Intangible Asset, Expected Amortization, Year Four Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Right-of-use assets recorded in exchange for lease obligations Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Fair Value Measurements Debt Securities, Available-for-Sale [Line Items] Total operating lease expense, net Lease, Cost [Abstract] Total assets Business Combination, Recognized Asset Acquired, Asset Contingent consideration charges (gains), acquisition-related expenses, restructuring and other Total contingent consideration charges (gains), acquisition-related expenses, restructuring and other Acquisition-Related Charges, Impairment And Other Acquisition-Related Charges, Impairment And Other Level 2 Fair Value, Inputs, Level 2 [Member] Principal Owner Principal Owner [Member] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Business Combination [Domain] Business Combination [Domain] Contingent consideration charges (gains), acquisition-related expenses, restructuring and other Contingent Consideration Gain (Loss), Restructuring Charges and Other [Member] Contingent Consideration Gain (Loss), Restructuring Charges and Other Investment Categorization [Axis] Investment Categorization [Axis] Investment Categorization Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Four Lessee, Operating Lease, Liability, to be Paid, after Year Four Plan Name [Axis] Plan Name [Axis] PEO PEO [Member] Number of notices are filed Loss Contingency, Pending Claims, Number Employee Termination Benefits Employee Severance [Member] Non-cash investing and financing activities: Noncash Investing and Financing Items [Abstract] Interest income Investment Income, Interest Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Net income (loss) per common share: Earnings Per Share, Basic and Diluted EPS [Abstract] Earnings Per Share, Basic and Diluted EPS Premium Derivative, Premium Percentage Derivative, Premium Percentage Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Accumulated Deficit Retained Earnings [Member] Other net gains Provision for Other Losses Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Income Statement [Abstract] Income Statement [Abstract] Option extended term Contractual Obligation, Minimum Monthly Commission, Duration Contractual Obligation, Minimum Monthly Commission, Duration Intangible assets, net Intangible Assets, Net Intangible Assets, Net (Excluding Goodwill) Adjusted research and development Research And Development, Adjusted Research And Development, Adjusted Product and Service [Domain] Product and Service [Domain] Customer concentration Customer concentration Customer Concentration Risk [Member] Contractual interest expense Interest Expense, Debt, Excluding Amortization Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Business Combination [Table] Business Combination [Table] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Supplemental cash flow information related to operating leases Cash Flow, Operating Activities, Lessee [Abstract] Schedule of Reconciliation of Purchase Price to Total Consideration Transferred Business Combination, Recognized Asset Acquired and Liability Assumed [Table Text Block] City Area Code City Area Code Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Capitalized interest (Note 6) Interest Costs Capitalized Proceeds from Revolving Credit Facility Proceeds from Long-Term Lines of Credit Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Largest wholesaler Largest Customer [Member] Represents the largest customer of the entity. Interest receivable Interest Receivable Selling, general and administrative Selling, General and Administrative Expenses [Member] Total Lease, Cost Cost of goods sold Cost of Sales [Member] Goodwill Goodwill, beginning balance Goodwill, ending balance Goodwill Schedule of Operating Lease Expense and Other Operating Lease Information Lease, Cost [Table Text Block] Purchase of capped call transactions Payments for Derivative Instrument, Financing Activities Convertible notes receivable Notes Receivable, Fair Value Disclosure 0.750% Convertible senior notes due August 2025 Convertible Senior Notes Due 2025 [Member] Convertible Senior Notes Due 2025 Outside of the U.S. Non-US [Member] Number of paragraph certification Number Of Paragraph IV Certifications Number Of Paragraph IV Certifications Concentration Risk [Table] Concentration Risk [Table] Convertible Notes Receivable Convertible Notes Receivable [Member] Convertible Notes Receivable Supplemental cash flow information: Supplemental Cash Flow Information [Abstract] Cost Debt Securities, Available-for-Sale, Amortized Cost Accounts receivable Business Combination, Recognized Asset Acquired, Receivable, Current Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Other Performance Measure, Amount Other Performance Measure, Amount Expect to receive partial summary judgment Litigation Settlement, Amount Expected To Be Awarded from Other Party Litigation Settlement, Amount Expected To Be Awarded from Other Party Weighted Average Exercise Price (Per Share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Current portion of long-term debt, net Debt, Current Related and Nonrelated Parties [Domain] Related and Nonrelated Parties [Domain] Total fair value of the GQ Bio Acquisition Business Combination, Consideration Transferred and Preacquisition Equity Interest in Acquiree Derivative Instrument [Axis] Derivative Instrument [Axis] Entity [Domain] Entity [Domain] Net cash provided by (used in) investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation AmacaThera, Inc AmacaThera, Inc [Member] AmacaThera, Inc Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activity Lease liabilities Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Lease Liabilities Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Lease Liabilities Document Fiscal Year Focus Document Fiscal Year Focus Right-of-use assets, net Operating Lease, Right-of-Use Asset Effective tax rate (in percent) Effective Income Tax Rate Reconciliation, Percent Fixed lease costs Operating Lease, Cost Operating activities: Cash Provided by (Used in) Operating Activity, Continuing Operation [Abstract] Plan Name [Domain] Plan Name [Domain] Carrying Value Reported Value Measurement [Member] Acquisition-related expenses Business Combination, Acquisition-Related Cost, Expense Exercise of stock options (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period SEGMENT INFORMATION Segment Reporting Disclosure [Text Block] Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Increase (Decrease) in Stockholders' Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Total liabilities Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Acquisition-related contingent consideration Business Combination, Contingent Consideration, Liability Weighted Average Weighted Average [Member] Amortization of acquired intangible assets Amortization of Intangible Assets Selling, general and administrative Selling, General and Administrative Expense GQ Bio Therapeutics GmbH GQ Bio Therapeutics GmbH [Member] GQ Bio Therapeutics GmbH Deferred tax assets Deferred Income Tax Assets, Net Schedule of Accumulated Other Comprehensive Loss Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Depreciation of fixed assets and amortization of intangible assets Depreciation, Depletion and Amortization Initial conversion rate Debt Instrument, Convertible, Conversion Ratio Patent Infringement Patent Infringement [Member] Patent Infringement Reportable Segment Reportable Segment [Member] Reportable Segment Revolving Credit Facility Revolving Credit Facility [Member] Arrangement Duration Trading Arrangement Duration Payment of debt issuance and financing costs Payment of Financing and Stock Issuance Costs Segments [Axis] Segments [Axis] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Local Phone Number Local Phone Number Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Share price (in dollars per share) Closing sale price (in dollars per share) Share Price Cash and cash equivalents Business Combination, Recognized Asset Acquired, Cash and Cash Equivalent ASSETS Assets [Abstract] Credit Facility [Axis] Credit Facility [Axis] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Debt Instrument [Axis] Debt Instrument [Axis] Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Business Combination [Line Items] Business Combination [Line Items] (Loss) gain on early extinguishment of debt Loss (gain) on early extinguishment of debt (Loss) gain on early extinguishment of debt Gain (Loss) on Extinguishment of Debt Credit Facility [Domain] Credit Facility [Domain] Stockholders’ equity: Equity, Attributable to Parent [Abstract] Purchase of treasury stock, inclusive of excise tax Purchase of treasury stock, inclusive of excise tax Treasury Stock, Value, Acquired, Cost Method Stated rate Debt Instrument, Interest Rate, Stated Percentage Lease liabilities Operating Lease, Liability, Noncurrent Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Entity Registrant Name Entity Registrant Name Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Basis of Presentation and Principles of Consolidation Basis of Presentation and Principles of Consolidation [Policy Text Block] Disclosure of accounting policy for basis of presentation and principles of consolidation. Equity investments Equity Securities without Readily Determinable Fair Value, Amount Number of operating segments Number of Operating Segments Schedule of Composition of the Company's Debt and Financing Obligations Schedule of Debt [Table Text Block] Payment of debt Payment of debt Repayments of Convertible Debt Machinery and equipment Machinery and Equipment [Member] Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Related and Nonrelated Parties [Axis] Related and Nonrelated Parties [Axis] Restatement Determination Date: Restatement Determination Date [Axis] Accounts Receivable Accounts Receivable [Member] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Schedule of Restructuring Charges Restructuring and Related Costs [Table Text Block] Total Interest Expense, Debt Debt Instrument, Convertible Terms Of Conversion [Axis] Debt Instrument, Convertible Terms Of Conversion [Axis] Debt Instrument, Convertible Terms Of Conversion LIABILITIES ASSUMED Business Combination, Recognized Liability Assumed, Liability [Abstract] Schedule of Carrying Amount and Fair Value of the Long-Term Debt Fair Value, Liabilities Measured on Recurring Basis [Table Text Block] Name Trading Arrangement, Individual Name Repurchase amount Debt Instrument, Repurchase Amount 2.125% Convertible senior notes due May 2029 Convertible Senior Notes Due 2029 [Member] Convertible Senior Notes Due 2029 Aggregate principal amount Debt Instrument, Face Amount Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Contingent consideration Contingent Consideration, Noncurrent Contingent Consideration, Noncurrent Name Awards Close in Time to MNPI Disclosures, Individual Name Income (loss) before income taxes: Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract] Cash payments made / settled Payments for Restructuring Unvested at beginning of period (in dollars per share) Unvested at end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Restructuring Type [Axis] Restructuring Type [Axis] Bupivacaine liposome injectable suspension Bupivacaine Liposome Injectable Suspension [Member] Bupivacaine Liposome Injectable Suspension Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Purchase of capped call transaction, net of tax Adjustments To Additional Paid In Capital, Purchase Of Capped Calls, Net Of Tax Adjustments To Additional Paid In Capital, Purchase Of Capped Calls, Net Of Tax Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Tax benefit OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax Acquired IPR&D In Process Research and Development [Member] Convertible Note Receivable Convertible Note Receivable [Member] Convertible Note Receivable EXPAREL EXPAREL [Member] EXPAREL/bupivacaine liposome injectable suspension [Member] Litigation Case [Axis] Litigation Case [Axis] Liability Class [Axis] Liability Class [Axis] Segments [Domain] Segments [Domain] Income Statement Location [Axis] Statement of Income Location, Balance [Axis] Foreign Income (Loss) from Continuing Operations before Income Taxes, Foreign Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy and NAV [Domain] Inventories, net Increase (Decrease) in Inventories Net Unrealized Gain (Loss) From Available-For-Sale Investments AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member] Less: accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Investment Categorization [Domain] Investment Categorization [Domain] Investment Categorization [Domain] 2025 Notes Senior Notes [Member] Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued and outstanding at September 30, 2025 and December 31, 2024 Preferred Stock, Value, Issued Impairments Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Impairments Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Impairments Total liabilities Business Combination, Recognized Liability Assumed, Liability Number of generic drug manufacturers Number Of Generic Drug Manufacturers Number Of Generic Drug Manufacturers All Executive Categories All Executive Categories [Member] Finished goods Inventory, Finished Goods, Net of Reserves Common stock, par value $0.001; 250,000,000 shares authorized; 47,735,248 shares issued and 42,965,902 shares outstanding at September 30, 2025 and 47,077,844 shares issued and 46,240,604 shares outstanding at December 31, 2024 Common Stock, Value, Issued Short-term available-for-sale investments Short-Term Investments Prepaid expenses and other assets Business Combination, Recognized Asset Acquired, Prepaid Expense and Other Asset, Current Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Commitments and contingencies (Note 16) Commitments and Contingencies Term loan A facility maturing March 2028 Term Loan A Facility Due March 2028 [Member] Term Loan A Facility Due March 2028 Business Combination [Axis] Business Combination [Axis] Total fair value of the GQ Bio Acquisition Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred Current: Short-Term Investments [Member] Numerator: Net Income (Loss) Available to Common Stockholders, Basic [Abstract] Concentration Risk [Line Items] Concentration of Major Customers Concentration Risk [Line Items] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Total Three Largest Customers [Member] Three Largest Customers Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Convertible senior notes Debt Instrument, Fair Value Disclosure Range of milestone payment Revenue from Contract with Customer, Milestone Payments, Maximum Revenue from Contract with Customer, Milestone Payments, Maximum Scenario [Axis] Scenario [Axis] Deferred tax liability Business Combination, Recognized Liability Assumed, Deferred Tax Liability Derivative Contract [Domain] Derivative Contract [Domain] Key employee holdback recognition year one Business Combination, Liabilities Arising from Contingencies, Percent, Year One Business Combination, Liabilities Arising from Contingencies, Percent, Year One All Individuals All Individuals [Member] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Contract Termination Costs Contract Termination [Member] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Purchases of fixed assets Payments to Acquire Property, Plant, and Equipment Name Forgone Recovery, Individual Name Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Number of employee compensation Business Combination, Contingency Recognized at Acquisition Date, Employee Compensation Liability Assumed, Number Of Employees Business Combination, Contingency Recognized at Acquisition Date, Employee Compensation Liability Assumed, Number Of Employees Purchase price of common stock, ESPP (as a percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Foreign currency adjustments Goodwill, Foreign Currency Translation, Gain (Loss) Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Geographical [Axis] Geographical [Axis] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Accrued expenses Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses Forecast Forecast [Member] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Title of 12(b) Security Title of 12(b) Security Flexion Acquisition Flexion Acquisition [Member] Flexion Acquisition Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Net income (loss) per common share: Earnings Per Share [Abstract] Restructuring Plan [Axis] Restructuring Plan [Axis] Total other income (expense), net Total other income (expense), net Nonoperating Income (Expense) Schedule of Potential Dilutive Effect of the Securities Excluded from the Calculation of Diluted Loss Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Non-cancelable contractual commitment 2026 Contractual Obligation, to be Paid, Year One Outstanding principal balance Debt Instrument, Repaid, Principal Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Purchase of treasury stock, inclusive of excise tax (in shares) Purchase of treasury stock, inclusive of excise tax (in shares) Treasury Stock, Shares, Acquired Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Award Timing Disclosures [Line Items] Baylor College of Medicine (Baylor) Baylor College of Medicine (Baylor) [Member] Baylor College of Medicine (Baylor) Schedule of Components of Inventories Schedule of Inventory, Current [Table Text Block] STOCKHOLDERS' EQUITY Equity [Text Block] Effective interest rate on total debt (in percent) Debt Instrument, Interest Rate During Period Payment terms Accounts Receivable, Payment Terms Accounts Receivable, Payment Terms Net income (loss) Net income (loss) Net income (loss) Net income (loss) Net Income (Loss) Attributable to Parent Subsequent Event [Table] Subsequent Event [Table] Key employee holdback agreement Business Combination, Contingency Recognized at Acquisition Date, Liability Assumed, Fair Value Construction in progress Construction in Progress [Member] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Purchase of treasury stock, inclusive of broker fees Payments for Repurchase of Common Stock Adoption Date Trading Arrangement Adoption Date Base Rate Base Rate [Member] iovera° iovera° [Member] iovera° [Member] Major Customers [Axis] Customer [Axis] Financing activities: Cash Provided by (Used in) Financing Activity, Continuing Operation [Abstract] Customer relationships Customer Relationships [Member] Income (loss) from operations Operating Income (Loss) Line of Credit Line of Credit [Member] Accumulated deficit Retained Earnings (Accumulated Deficit) Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Indefinite-lived intangible asset impairment Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill) GQ Bio Acquisition GQ Bio Acquisition [Member] GQ Bio Acquisition Subsequent Event Type [Domain] Subsequent Event Type [Domain] Prepaid expenses and other assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Prepaid Expenses And Other Assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Prepaid Expenses And Other Assets Second largest wholesaler Second Largest Customer [Member] Represents the second largest customer of the entity. Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Other, net Other Nonoperating Income (Expense) Statement [Table] Statement [Table] Deferred taxes Deferred Income Tax Expense (Benefit) Adjustments to reconcile net income (loss) to net cash provided by operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Revenue Revenue Benchmark [Member] Total fair value of the GQ Bio Acquisition Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), and Goodwill Variable Rate [Domain] Variable Rate [Domain] DESCRIPTION OF BUSINESS Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Research Development Foundation Research Development Foundation [Member] Research Development Foundation Schedule of Investments without Readily Determinable Fair Value Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] All Adjustments to Compensation All Adjustments to Compensation [Member] Amendment Flag Amendment Flag Stock incentive plan, awards reserved for issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Major Customer Three Major Customer Three [Member] Represents the major customer of the entity. Treasury stock, at cost, inclusive of excise tax and broker fees, 4,769,346 and 837,240 shares at September 30, 2025 and December 31, 2024, respectively Treasury Stock, Common, Value Equity Investment And Convertible Note Receivable Equity Investment And Convertible Note Receivable [Member] Equity Investment And Convertible Note Receivable Borrowings Debt Issuance Costs, Line of Credit Arrangements, Net Termination Date Trading Arrangement Termination Date Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Receivable [Domain] Receivable [Domain] Raw materials Inventory, Raw Materials, Net of Reserves In-process research and development (IPR&D) Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Indefinite-Lived Weighted average discount rate (in percent) Operating Lease, Weighted Average Discount Rate, Percent Schedule of the Company's Stock Option Activity and Restricted Stock Unit Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Basic (in shares) Weighted average common shares outstanding - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Accounts receivable Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Receivable Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Receivable Schedule of Computation of Basic and Diluted Net Loss Per Common Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Subsequent Events [Abstract] Subsequent Events [Abstract] Segment Reporting [Abstract] Cost of goods sold Cost of Revenue Debt Disclosure [Abstract] Debt Disclosure [Abstract] Other income (expense): Nonoperating Income (Expense) [Abstract] Scenario, Unspecified [Domain] Scenario [Domain] Debt instrument, unamortized discount Discount on debt Debt Instrument, Unamortized Discount Interest payment Interest Paid, Including Capitalized Interest, Operating and Investing Activities Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Schedule of Total Interest Expense Recognized Related to the Notes Schedule of Interest Expense [Table Text Block] Tabular disclosure of the amount of interest rate expenses related to convertible notes. Stock Incentive Plans Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Convertible debt, premium on common stock Debt Instrument, Conversion Obligation Premium on Common Stock Represents the percentage of premium added to the last reported sale price of the common stock of the entity to arrive at the conversion price of the debt instrument. Settled notes receivable Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements Adjusted other income (expense) Other Income Expense Adjusted Other Income Expense Adjusted SUBSEQUENT EVENTS Subsequent Events [Text Block] Insider Trading Arrangements [Line Items] Forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Equity Investments Equity Securities [Member] Total liabilities Liabilities Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Product Product Concentration Risk [Member] Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Repurchased aggregate principal Debt Instrument, Repurchased Face Amount Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Key employee holdback agreement payment period Business Combination, Liabilities Arising from Contingencies, Period Of Recognized Business Combination, Liabilities Arising from Contingencies, Period Of Recognized Asset-backed securities Asset-Backed Securities [Member] Cap price (in USD per share) Derivative, Capped Call Price Derivative, Capped Call Price Variable Rate [Axis] Variable Rate [Axis] Counterparty Name [Axis] Counterparty Name [Axis] Threshold trading days Debt Instrument, Convertible, Threshold Trading Days Fair Value Debt Securities, Available-for-Sale Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Term two Debt Conversion Terms Two [Member] Debt Conversion Terms Two Non-NEOs Non-NEOs [Member]